Avectas
PrivateLast Round
Grant
Apr 22, 2021
Total Funding Raised
$31.28M
Company Overview
Avectas is a biotechnology company that has developed a cell engineering platform intended to enable the ex vivo manufacture of gene-modified cell therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avectas Comparables
Compare Avectas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 85% | |
| CellFE | 85% | |
| Kytopen | 84% | |
Avectas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 22, 2021 | ||||
| Series C | Apr 16, 2020 | ||||
| VC Round | Apr 9, 2019 | ||||
| Grant | Mar 20, 2018 |
Key People
Founding team and executive leadership
Avectas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Disruptive Technologies Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 23, 2026
Monthly visitors increased 506% MoM.
- Jan 6, 2026
Monthly visitors increased 174% MoM.
Avectas Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avectas's valuation, stock price, and market status.